"CAS 932372-01-5，Asapiprant, World Biggest Manufacturer
CAS 932372-01-5，Asapiprant, , EE 99.9%, CAS 932372-01-5，Asapiprant, ,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
CAS 932372-01-5，Asapiprant, stable novel crystalline or amorphous form both we have, CAS 932372-01-5，Asapiprant, no any IP problem. CAS 932372-01-5，Asapiprant, DMF filling, free sample of CAS 932372-01-5，Asapiprant, .
EOS Med Chem have already carried out CAS 932372-01-5，Asapiprant, batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For CAS 932372-01-5，Asapiprant, , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is CAS 932372-01-5，Asapiprant, Intermeidates list, most from GMP plant:
Asapiprant, CAS 932372-01-5 Intermediate, 5106-98-9, stock 7.8kg, assay 98.3%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 22483-09-6, stock 2kg, assay 98.4%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 1070796-23-4, stock 5.6kg, assay 98%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932373-07-4, stock 3.8kg, assay 98%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932373-08-5, stock 4.9kg, assay 98.2%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932372-87-7, stock 6.6kg, assay 98.7%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932373-09-6, stock 5.6kg, assay 98.6%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932373-10-9, stock 9.6kg, assay 99%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932372-81-1, stock 8.1kg, assay 98.7%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 98995-40-5, stock 9.6kg, assay 98.3%, White powder.
Asapiprant, CAS 932372-01-5 Intermediate, 932372-86-6, stock 3.7kg, assay 98.7%, White powder.
CAS 932372-01-5，Asapiprant, HNMR, MASS, COA, MSDS we have.
CAS 932372-01-5，Asapiprant, , free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com"
